ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2927

What Are the Optimal MRI Lesion Cut-Offs That Define Active and Structural Lesions in the Sacroiliac Joint As Being Typical of Axial Spondyloarthritis By Expert Readers?

Walter P. Maksymowych1,2, Pedro Machado3, Ulrich Weber4, Xenofon Baraliakos5, Joachim Sieper6, Stephanie Wichuk1, Denis Poddubnyy6, Mikkel Østergaard7, Joel Paschke2, Robert G. Lambert1 and Susanne J Pedersen7, 1University of Alberta, Edmonton, AB, Canada, 2CaRE Arthritis, Edmonton, AB, Canada, 3University College London, London, United Kingdom, 4University of Southern Denmark, Odense, Denmark, 5Rheumazentrum Ruhrgebiet Herne, Herne, Germany, 6Charité Universitätsmeidzin Berlin, Berlin, Germany, 7COPECARE University of Copenhagen, Copenhagen, Denmark

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: classification criteria and spondylarthritis, MRI

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, October 24, 2018

Title: 6W011 ACR Abstract: Spondyloarthritis Incl PsA–Clinical VI: Imaging of Axial SpA (2922–2927)

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose:

Defining what constitutes a definite MRI lesion in the SIJ typical of axSpA has been hampered by lack of international consensus for standardized lesion descriptions and definitions. The ASAS MRI group has generated updated consensus lesion definitions (ASAS_MRI_defn) for the spectrum of MRI lesions in the SIJ and these have been applied to the assessment of MRI images from the ASAS Classification Cohort (ASAS-CC) by 7 experts in MRI interpretation from the ASAS-MRI group. We aimed to determine optimal quantitative SPARCC cut-offs for specific MRI lesions for a definite MRI lesion typical of axSpA, the external reference being majority reader decision as to the presence of an active or structural lesion typical of axSpA.


Methods:

ASAS_MRI_defn were recorded in an eCRF that comprises global assessment (active or structural lesion typical of axSpA present/absent), links to reference images, and detailed scoring of lesions per SIJ quadrant (SPARCC SIJ inflammation, SPARCC SIJ structural). MRI images were available from 278 of the 495 cases that had MRI performed in the ASAS-CC. Detailed SPARCC scoring data was based only on assessment of images in DICOM format (n =175). We calculated sensitivity and specificity for varying numbers of SIJ quadrants with bone marrow edema (BME), erosion, and fatty lesions where a majority of readers (≥4/7) agreed as to the presence of an active or structural lesion typical of axSpA.


Results:

BME was the most frequent lesion (SPARCC BME score, mean (SD) =14.4(15.5) in cases where a majority of readers agreed there was an active lesion typical of axSpA. For majority agreement as to the presence of a structural lesion typical of axSpA, the most frequent lesions were fatty lesion, and erosion (mean (SD) SPARCC score per case of 8.6(9.1) and 8.2(5.7), respectively). Other structural lesions were much less frequent. Optimal SPARCC cut-offs that focus on specificity (≥95%) were BME ≥3 for defining an active lesion, and fatty lesion ≥3 and erosion ≥2 for defining a structural lesion (Table).


Conclusion:

The ASAS MRI specific lesion definitions perform well when judged against the expert opinion of ASAS-MRI readers. In particular, the optimal cut-off for an erosion lesion, as defined by ASAS, has similar performance to the optimal cut-off for BME.

Table. Sensitivities and specificities of cut-offs for SIJ lesion scores (number of SIJ quadrants) according to presence of definite active or structural lesion typical for axSpA (≥4/7 readers in agreement)

 

Sensitivity (95% CI)

Specificity (95% CI)

Majority agree active lesions indicative of axSpA present

BME Score ≥2

80.0 (65.4 – 90.4)

93.9 (88.2 – 97.3)

BME Score ≥3

77.8 (62.9 – 88.8)

99.2 (95.8 – 100.0)

Majority agree structural lesions indicative of axSpA present

Fatty lesion (any) ≥2

63.2 (46.0 – 78.2)

90.5 (83.7 – 95.2)

Fatty lesion (any) ≥3

55.3 (38.3 – 71.4)

94.8 (89.1 – 98.1)

Erosion Score ≥2

84.2 (68.7 – 94.0)

96.6 (91.4 – 99.1)

Erosion Score ≥3

79.0 (62.7 – 90.4)

99.1 (95.3 – 100.0)

Majority agree active OR structural lesions indicative of axSpA present

BME Score ≥2

70.4 (56.4 – 82.0)

95.0 (89.5 – 98.2)

BME Score ≥3

66.7 (52.5 – 78.9)

100.0 (97.0 – 100.0)

Fatty lesion ≥2

50.0 (36.1 – 63.9)

93.4 (87.4 – 97.1)

Fatty lesion ≥3

40.7 (27.6 – 55.0)

95.9 (90.6 – 98.6)

Erosion Score ≥2

63.0 (48.7 – 75.7)

98.4 (94.2 – 99.8

Erosion Score ≥3

57.4 (43.2 – 70.8)

100.0 (97.0 – 100)

 


Disclosure: W. P. Maksymowych, CaRE rthritis, 9; P. Machado, None; U. Weber, None; X. Baraliakos, None; J. Sieper, None; S. Wichuk, None; D. Poddubnyy, None; M. Østergaard, None; J. Paschke, None; R. G. Lambert, None; S. J. Pedersen, None.

To cite this abstract in AMA style:

Maksymowych WP, Machado P, Weber U, Baraliakos X, Sieper J, Wichuk S, Poddubnyy D, Østergaard M, Paschke J, Lambert RG, Pedersen SJ. What Are the Optimal MRI Lesion Cut-Offs That Define Active and Structural Lesions in the Sacroiliac Joint As Being Typical of Axial Spondyloarthritis By Expert Readers? [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/what-are-the-optimal-mri-lesion-cut-offs-that-define-active-and-structural-lesions-in-the-sacroiliac-joint-as-being-typical-of-axial-spondyloarthritis-by-expert-readers/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/what-are-the-optimal-mri-lesion-cut-offs-that-define-active-and-structural-lesions-in-the-sacroiliac-joint-as-being-typical-of-axial-spondyloarthritis-by-expert-readers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology